EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited-Reference-Cited by-同舟云学术

EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited

Published:2017-12-08 Issue:3 Volume:34 Page:475-485
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Kamin Wolfgang¹,Funk Petra²,Seifert Georg³,Zimmermann Andrea²,Lehmacher Walter⁴

Affiliation:

1. Clinic for Paediatrics, Evangelic Hospital Hamm, Hamm, Germany;

2. Clinical Research Department, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany;

3. Clinic for Paediatrics, Charité - Universitätsmedizin Berlin, Berlin, Germany;

4. Institute for Medical Statistics, Informatics and Epidemiology of the University of Cologne, Cologne, Germany

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1402754

Reference66 articles.

1. Goh DY, Shek LP, Wah LB. Acute respiratory tract infections in children: outpatient management. Bulletin - National University Hospital Singapore [Internet]. 1999. Available online at: https://www.nuh.com.sg/wbn/slot/u3609/Education/Healthcare%20Professionals/Education%20&%20Training%20Opportunities/Bulletin/bulletin_10.pdf. [Last accessed 13 October 2016]

2. Duration of symptoms of respiratory tract infections in children: systematic review

3. Management of respiratory tract infections in children

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in systemic immune inflammatory indices in non-small cell lung cancer: A review;Medicine;2024-05-03

2. Using targeted second-generation sequencing technique to guide clinical diagnosis and the effect of medication on the therapeutic effect and prognosis of respiratory tract infection in children: An observational study;Medicine;2024-05-03

3. Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data;Frontiers in Pharmacology;2024-02-23

4. Effects of EPs 7630 on Illness Absence from Childcare or School due to Acute Bronchitis—A Meta-analysis;Journal of Pediatric Infectious Diseases;2024-01-12

5. Stevens’ Cure (Umckaloabo)—the vindication of a patent medicine;Frontiers in Pharmacology;2024-01-03